Review Article
A Meta-Analysis of the Association between DNMT1 Polymorphisms and Cancer Risk
Table 1
Characteristics of the included studies in this meta-analysis.
| Author | Year | Ethnicity | Cancer type | Genotyping method | Case | Control | Total | MM | WM | WW | Total | MM | WM | WW |
| For DNMT1 rs16999593 T/C polymorphism | Wang [12] | 2014 | Chinese | Cervical cancer | Sequencing | 100 | 48 | 44 | 8 | 100 | 70 | 25 | 5 | Gao [13] | 2015 | Chinese | Gastric cancer | Sequencing | 310 | 180 | 112 | 18 | 420 | 281 | 117 | 22 | Li [14] | 2015 | Chinese | Esophageal cancer | MassARRAY | 258 | 138 | 80 | 40 | 260 | 127 | 109 | 24 | He et al. [11] | 2014 | Chinese | Prostate cancer | MassARRAY | 155 | 94 | 53 | 8 | 155 | 73 | 67 | 15 | Sun [7] | 2012 | Chinese | Breast cancer | MassARRAY | 1327 | 425 | 224 | 29 | 1440 | 504 | 202 | 28 | Xiang et al. [6] | 2010 | Chinese | Breast cancer | PCR-RFLP | 305 | 239 | 64 | 2 | 314 | 220 | 89 | 5 | Jiang et al. [9] | 2012 | Chinese | Gastric cancer | Sequencing | 447 | 283 | 144 | 20 | 961 | 659 | 273 | 29 | Yang et al. [10] | 2012 | Chinese | Gastric cancer | MALDI-TOF | 242 | 141 | 89 | 12 | 294 | 196 | 83 | 15 | Tao et al. [15] | 2015 | Chinese | Breast cancer | Sequencing | 234 | 68 | 164 | 2 | 300 | 180 | 105 | 15 | For DNMT1 rs2228611 G/A polymorphism | Gao [13] | 2015 | Chinese | Gastric cancer | Sequencing | 310 | 167 | 128 | 15 | 420 | 232 | 163 | 25 | Li [14] | 2015 | Chinese | Esophageal cancer | MassARRAY | 258 | 131 | 85 | 42 | 260 | 119 | 113 | 28 | He et al. [11] | 2014 | Chinese | Prostate cancer | MassARRAY | 155 | 82 | 61 | 12 | 155 | 79 | 64 | 12 | Xiang et al. [6] | 2010 | Chinese | Breast cancer | PCR–RFLP | 305 | 125 | 149 | 31 | 314 | 154 | 121 | 39 | Yang et al. [21] | 2016 | Chinese | Renal cell carcinoma | PCR–RFLP | 293 | 152 | 117 | 24 | 293 | 139 | 133 | 21 | Yang et al. [10] | 2012 | Chinese | Gastric cancer | MALDI-TOF | 242 | 132 | 97 | 13 | 285 | 160 | 99 | 26 | Sun [7] | 2012 | Chinese | Breast cancer | MassARRAY | 678 | 341 | 279 | 58 | 733 | 369 | 303 | 61 | Mostowska et al. [18] | 2013 | Polish | Ovarian cancer | PCR–RFLP | 159 | 28 | 74 | 57 | 210 | 44 | 94 | 72 | Xi et al. [19] | 2014 | Chinese | Breast cancer | MALDI-TOF | 810 | 385 | 362 | 63 | 848 | 432 | 343 | 73 | Lin et al. [20] | 2015 | Chinese | Breast cancer | MALDI-TOF | 233 | 107 | 109 | 17 | 236 | 120 | 94 | 22 | Khatami et al. [8] | 2009 | Iranian | Gastric cancer | PCR–RFLP | 200 | 34 | 50 | 16 | 112 | 32 | 62 | 18 | For DNMT1 rs2228612 A/G polymorphism | Sun [7] | 2012 | Chinese | Breast cancer | MassARRAY | 675 | 254 | 273 | 148 | 731 | 308 | 290 | 133 | Chang et al. [17] | 2014 | Chinese | Esophageal cancer | SNPlex | 137 | 52 | 56 | 29 | 357 | 100 | 200 | 57 | Chang et al. [17] | 2014 | Chinese | Stomach cancer | SNPlex | 143 | 43 | 72 | 28 | 357 | 100 | 200 | 57 | Chang et al. [17] | 2014 | Chinese | Liver cancer | SNPlex | 158 | 48 | 74 | 36 | 357 | 100 | 200 | 57 | Kullmann et al. [16] | 2013 | Caucasian | Breast cancer | TaqMan | 221 | 193 | 28 | 0 | 221 | 180 | 35 | 6 |
|
|
Abbreviations: W, wild-type allele; M, mutant-type allele.
|